vs
Side-by-side financial comparison of Neuphoria Therapeutics Inc. (NEUP) and SOLAI Ltd (SLAI). Click either name above to swap in a different company.
Neuphoria Therapeutics Inc. is the larger business by last-quarter revenue ($15.0M vs $11.0M, roughly 1.4× SOLAI Ltd). Neuphoria Therapeutics Inc. runs the higher net margin — 75.1% vs -126.2%, a 201.3% gap on every dollar of revenue.
Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.
NEUP vs SLAI — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $11.0M |
| Net Profit | $11.3M | $-13.9M |
| Gross Margin | — | 0.1% |
| Operating Margin | 79.8% | -126.2% |
| Net Margin | 75.1% | -126.2% |
| Revenue YoY | — | -43.1% |
| Net Profit YoY | — | -173.4% |
| EPS (diluted) | $6.55 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $11.0M | ||
| Q1 25 | $15.0M | — | ||
| Q2 24 | — | $19.4M |
| Q2 25 | — | $-13.9M | ||
| Q1 25 | $11.3M | — | ||
| Q2 24 | — | $18.9M |
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 52.4% |
| Q2 25 | — | -126.2% | ||
| Q1 25 | 79.8% | — | ||
| Q2 24 | — | -2.6% |
| Q2 25 | — | -126.2% | ||
| Q1 25 | 75.1% | — | ||
| Q2 24 | — | 97.9% |
| Q2 25 | — | $-0.01 | ||
| Q1 25 | $6.55 | — | ||
| Q2 24 | — | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.0M | $1.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $26.0M | $43.8M |
| Total Assets | $30.7M | $69.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $1.2M | ||
| Q1 25 | $17.0M | — | ||
| Q2 24 | — | $2.3M |
| Q2 25 | — | $43.8M | ||
| Q1 25 | $26.0M | — | ||
| Q2 24 | — | $45.9M |
| Q2 25 | — | $69.1M | ||
| Q1 25 | $30.7M | — | ||
| Q2 24 | — | $63.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.5M | $-17.0M |
| Free Cash FlowOCF − Capex | — | $-17.0M |
| FCF MarginFCF / Revenue | — | -154.2% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-17.0M | ||
| Q1 25 | $11.5M | — | ||
| Q2 24 | — | $-12.1M |
| Q2 25 | — | $-17.0M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — |
| Q2 25 | — | -154.2% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — |
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — |
| Q2 25 | — | — | ||
| Q1 25 | 1.02× | — | ||
| Q2 24 | — | -0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NEUP
Segment breakdown not available.
SLAI
| Data center | $6.5M | 59% |
| Cryptocurrency mining | $4.6M | 41% |
